Azithromycin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Azithromycin
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Azithromycin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 26 USDMF, 9 CEP/COS, 8 JDMF, 9 EU WC, 12 KDMF, 2 NDC API, 42 Listed Suppliers, $ API Reference Price

71 API Suppliers
26 USDMF
9 CEP/COS
8 JDMF
9 EU WC
12 KDMF
2 NDC API
42 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

589 FDF Dossiers, 86 FDA Orange Book, 208 Europe, 14 Canada, 31 Australia, 27 South Africa, 223 Listed Dossiers

589 FDF Dossiers
86 FDA Orange Book
208 Europe
14 Canada
31 Australia
27 South Africa
223 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SUSPENSION;ORAL - EQ 1GM BASE/PACKET, FOR SUSPENSION;ORAL - EQ 100MG BASE/5ML, FOR SUSPENSION;ORAL - EQ 200MG BASE/5ML, TABLET;ORAL - EQ 250MG BASE, TABLET;ORAL - EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL, TABLET;ORAL - EQ 500MG BASE, FOR SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2GM BASE/BOT

FOR SUSPENSION;ORAL - EQ 1GM BASE/PACKET
FOR SUSPENSION;ORAL - EQ 100MG BASE/5ML
FOR SUSPENSION;ORAL - EQ 200MG BASE/5ML
TABLET;ORAL - EQ 250MG BASE
TABLET;ORAL - EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 500MG BASE/VIAL
TABLET;ORAL - EQ 500MG BASE
FOR SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2GM BASE/BOT

RELATED EXCIPIENT COMPANIES

5 Evonik, 4 Rochem International Inc, 21 SPI Pharma, 2 Seqens, 5 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 18 BASF, 1 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 1 Lubrizol Life Science Health, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 32 Controlled & Modified Release, 32 Disintegrants & Superdisintegrants, 30 Direct Compression, 29 Taste Masking, 28 Thickeners and Stabilizers, 25 Granulation, 19 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 16 Solubilizers, 16 Parenteral, 15 Topical, 14 Film Formers & Plasticizers, 14 Co-Processed Excipients, 7 Emulsifying Agents, 7 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Coloring Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents

76 Fillers, Diluents & Binders
56 Coating Systems & Additives
32 Controlled & Modified Release
32 Disintegrants & Superdisintegrants
30 Direct Compression
29 Taste Masking
28 Thickeners and Stabilizers
25 Granulation
19 Chewable & Orodispersible Aids
17 Lubricants & Glidants
16 Solubilizers
16 Parenteral
15 Topical
14 Film Formers & Plasticizers
14 Co-Processed Excipients
7 Emulsifying Agents
7 API Stability Enhancers
5 Rheology Modifiers
5 Empty Capsules
4 Coloring Agents
4 Vegetarian Capsules
2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 97 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
97 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 208 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
208 Finished Drug Prices
10 Annual Reports

MARKET PLACE

83 APIs, 38 FDF Dossiers, 1 Intermediates

83 APIs
38 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

2 US Patents, 3 Health Canada Patents

2 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 8 USP, 9 Others

4 EDQM
8 USP
9 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 187 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Merck Canada Inc.

filter Patent Reset all filters

3 All

01 22254682

02 12368637

filter Product Reset all filters

3 All

01 3Azithromycin

filter Dosage Reset all filters

3 All

01 2Ophthalmic Solution

02 1Ophthalmic solution

filter Exp Date Reset all filters

3 All

01 22018-11-30

02 12020-03-27

Product Main Page

01

Merck Canada Inc.

Azithromycin

BioAsia

Not Confirmed

Merck Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-11-30

Date Granted : 2003-07-08

Azithromycin

Brand Name : AZASITE

Patent Number : 2254682

Filing Date : 1998-11-30

Strength per Unit : 1% w / w

Dosage Form : Ophthalmic solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2018-11-30

Date Granted : 2003-07-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Merck Canada Inc.

Azithromycin

BioAsia

Not Confirmed

Merck Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-11-30

Date Granted : 2003-07-08

Azithromycin

Brand Name : AZASITE

Patent Number : 2254682

Filing Date : 1998-11-30

Strength per Unit : 1% w / w

Dosage Form : Ophthalmic Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2018-11-30

Date Granted : 2003-07-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Merck Canada Inc.

Azithromycin

BioAsia

Not Confirmed

Merck Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-03-27

Date Granted : 2011-01-18

Azithromycin

Brand Name : AZASITE

Patent Number : 2368637

Filing Date : 2000-03-27

Strength per Unit : 1% w / w

Dosage Form : Ophthalmic Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2020-03-27

Date Granted : 2011-01-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!